Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Muller

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 1998
S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidolM J Millan, A Gobert, A Newman-Tancredi, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 16, 2017
Missed opportunities for earlier diagnosis of rifampicin-resistant tuberculosis despite access to Xpert<sup>®</sup> MTB/RIFE Mohr, J Daniels, O Muller, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 1998
S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidolM J Millan, R Schreiber, A Dekeyne, et al.
Trials|October 27, 2021
Recovering arm function in chronic stroke patients using combined anodal HD-tDCS and virtual reality therapy (ReArm): a study protocol for a randomized controlled trialCamille O Muller, Makii Muthalib, Denis Mottet, et al.
Nature Plants|December 17, 2025
Engineering vascular potassium transport increases yield and drought resilience of cassavaW Zierer, M Fritzler, T J Chiu, et al.
Journal of Imaging Informatics in Medicine|April 18, 2025
Revisiting Anatomy of Anorectal Malformations with a Symbolic AI Segmentation Method Applied on Diffusion MRI: The Lumbosacral Plexus Development and Microarchitecture Is Different in High and Low TypesJ Goulin, G La Barbera, A Delmonte, et al.
Gut|May 13, 2003
Mutant K-ras2 in serumH J N Andreyev, R Benamouzig, M Beranek, et al.
Global Change Biology|July 7, 2015
Sun-induced fluorescence - a new probe of photosynthesis: First maps from the imaging spectrometer HyPlantU Rascher, L Alonso, A Burkart, et al.
British Journal of Cancer|September 5, 2001
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' studyH J Andreyev, A R Norman, D Cunningham, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 1998
S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidolM J Millan, A Gobert, A Newman-Tancredi, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 16, 2017
Missed opportunities for earlier diagnosis of rifampicin-resistant tuberculosis despite access to Xpert<sup>®</sup> MTB/RIFE Mohr, J Daniels, O Muller, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 1998
S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidolM J Millan, R Schreiber, A Dekeyne, et al.
Trials|October 27, 2021
Recovering arm function in chronic stroke patients using combined anodal HD-tDCS and virtual reality therapy (ReArm): a study protocol for a randomized controlled trialCamille O Muller, Makii Muthalib, Denis Mottet, et al.
Nature Plants|December 17, 2025
Engineering vascular potassium transport increases yield and drought resilience of cassavaW Zierer, M Fritzler, T J Chiu, et al.
Journal of Imaging Informatics in Medicine|April 18, 2025
Revisiting Anatomy of Anorectal Malformations with a Symbolic AI Segmentation Method Applied on Diffusion MRI: The Lumbosacral Plexus Development and Microarchitecture Is Different in High and Low TypesJ Goulin, G La Barbera, A Delmonte, et al.
Gut|May 13, 2003
Mutant K-ras2 in serumH J N Andreyev, R Benamouzig, M Beranek, et al.
Global Change Biology|July 7, 2015
Sun-induced fluorescence - a new probe of photosynthesis: First maps from the imaging spectrometer HyPlantU Rascher, L Alonso, A Burkart, et al.
British Journal of Cancer|September 5, 2001
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' studyH J Andreyev, A R Norman, D Cunningham, et al.
Pageof 9